Oxcarbazepine
Therapeutic Category
- Anti-convulsant
Innovator Brand
GMP
DMF
Filed
![USDMF Assessed USDMF Assessed](https://www.ctxls.com/wp-content/uploads/2022/10/USDMF-assessed.png)
![CEP CEP](https://www.ctxls.com/wp-content/uploads/2022/10/CEP.png)
![ANVISA ANVISA](https://www.ctxls.com/wp-content/uploads/2022/10/ANVISA.png)
Under Filing
![MOH Russia MOH Russia](https://www.ctxls.com/wp-content/uploads/2022/10/MOH.png)
Sample
Indication
Oxcarbazepine known under Brandname TRILEPTAL or OXTELLAR is indicated as monotherapy in the treatment of partial-onset seizures in patients 4 years of age and older, and as adjunctive therapy in the treatment of partial-onset seizures in patients 2 years of age and older.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Oxcarbazepine with CAS Number: 28721-07-5. We are a leading exporter of Oxcarbazepine with CAS Number:28721-07-5. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Iran, Middle East and other emerging markets.
CTX Lifesciences is one of the leading API manufacturer & supplier of Oxcarbazepine with CAS Number:28721-07-5. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File ( DMF ). Our manufacturing plant at Surat,India has accreditation by US-FDA, EDQM, EMA, ANVISA, KFDA, MOH-IRAN, Health Canada & Russian Authorities.
Please also check other API products in the same segment as below.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.